Champions Oncology, Inc. (FRA:2I3)

Champions Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	85	86	62	60	99	119
Market Cap Growth	-30.55%	40.09%	2.01%	-38.66%	-17.49%	42.38%
Enterprise Value	83	89	65	58	99	119
Last Close Price	6.05	6.40	4.50	4.42	7.40	9.15
PE Ratio	39.56	20.85	-	-	189.51	396.90
PS Ratio	1.69	1.72	1.32	1.24	2.12	3.50
PB Ratio	23.29	25.98	-34.65	14.39	11.42	19.34
P/TBV Ratio	25.70	28.51	-	15.51	11.85	20.26
P/FCF Ratio	17.47	14.01	-	60.64	25.25	-
P/OCF Ratio	15.84	13.27	-	16.80	15.99	-
EV/Sales Ratio	1.69	1.78	1.38	1.19	2.13	3.48
EV/EBITDA Ratio	17.07	15.65	-	-	46.90	92.05
EV/EBIT Ratio	39.98	20.94	-	-	172.63	389.82
EV/FCF Ratio	16.95	14.51	-	58.12	25.48	-
Debt / Equity Ratio	1.28	1.68	-3.90	1.86	1.04	1.29
Debt / EBITDA Ratio	0.94	0.76	-	-	2.29	3.37
Debt / FCF Ratio	0.96	0.90	-	7.82	2.30	-
Asset Turnover	2.11	1.95	1.66	1.55	1.56	1.70
Quick Ratio	0.91	0.88	0.56	0.83	1.06	1.04
Current Ratio	0.96	0.94	0.63	0.90	1.13	1.13
Return on Equity (ROE)	98.94%	503.05%	-532.46%	-77.70%	6.63%	5.78%
Return on Assets (ROA)	5.56%	10.36%	-14.31%	-7.98%	1.21%	0.95%
Return on Invested Capital (ROIC)	1811.03%	300.90%	-229.71%	-70.22%	5.21%	4.70%
Return on Capital Employed (ROCE)	30.70%	57.10%	-150.80%	-35.40%	3.40%	2.20%
Earnings Yield	2.53%	4.80%	-11.04%	-8.00%	0.53%	0.25%
FCF Yield	5.72%	7.14%	-10.58%	1.65%	3.96%	-3.45%
Buyback Yield / Dilution	-4.06%	-5.31%	-0.04%	4.37%	2.84%	-23.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.